46.Wright, Robin. ”How Iran Became a New Epicenter of the Coronavirus Outbreak”. The New Yorker. Archived from the original on 3 March 2020. Retrieved 7 March 2020.
47. Jump up to:a b c ”Iran Coronavirus”. Worldometer. Archived from the original on 9 March 2020. Retrieved 23 March 2020.
47. Jump up to:a b c ”Iran Coronavirus”. Worldometer. Archived from the original on 9 March 2020. Retrieved 23 March 2020.
48. Jump up to:a b c ”Iran Reports Its First 2 Cases of the New Coronavirus”. New York Times. Archived from the original on 19 February 2020. Retrieved 19 February 2020.
49. Jump up to:a b c ”How Iran Became a New Epicenter of the Coronavirus Outbreak”. The New Yorker. Archived from the original on 3 March 2020. Retrieved 5 March 2020.
50.Monajjemi, M.; Shahriari, S.; Mollaamin, F. Evaluation of Coronavirus Families & Covid-19 Proteins:
Molecular Modeling Study. Biointerface Res. Appl. Chem. 2020, 10, 6039-6057,
https://doi.org/10.33263/BRIAC105.60396057.
51. Roy, A.; Kucukural, A.; Zhang, Y. I-TASSER: a unified platform for automated protein structure and
function prediction. Nature Protocols 2010, 5, 725-738, https://doi.org/10.1038/nprot.2010.5.
52. Molecular Operating Environment (MOE), 2019.01; Chemical Computing Group ULC, 1010 Sherbrooke
St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2019.
53. Báez-Santos, Y.M.; Barraza, S.J.; Wilson, M.W.; Agius, M.P.; Mielech, A.M.; Davis, N.M.; Baker, S.C.; Larsen, S.D.; Mesecar, A.D. X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases. Journal of Medicinal Chemistry 2014, 57,
2393-2412 https://doi.org/10.1021/jm401712t.
54.Li ZY, Meng LY. 2020. Prevention and control of new coronavirus infection2020] in press. doi:10.3760/cma.j.issn.1002-0098.2020.0001 Andersson L, Andreasen JO, Day P, Heithersay G, Trope M, DiAngelis AJ
Kenny DJ, Sigurdsson A, Bourguignon C, Flores MT. 2012. International
55.Association of Dental Traumatology guidelines for the management of
traumatic dental injuries: 2. Avulsion of permanent teeth. Dent Traumatol.
28(2):88–96.
56.Centers for Disease Control and Prevention. 2020. Disease burden of influenza;
[accessed 2020 Feb 25]. https://www.cdc.gov/flu/about/burden/index.html.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon
RW, et al. 2020. A familial cluster of pneumonia associated with the 2019
novel coronavirus indicating person-to-person transmission: a study of a
family cluster. Lancet. 395(10223):514–523.
57.National Health Commission of China. 2020a. The diagnosis and treatment
protocol for novel coronavirus pneumonia (interim sixth edition) [accessed
2020 Feb 19]. http://www.gov.cn/zhengce/zhengceku/2020-02/19/content
58.The Chinese Preventive Medicine Association. 2020. An update on the epide-
miological characteristics of novel coronavirus pneumonia (COVID-19).
Chin J Epidemiol. 41(2):139–144.
59.Abdollahi, A., et al. (2020). ”The Novel Coronavirus SARS-CoV-2 Vulnerability Association with ABO/Rh Blood Types.” Iranian Journal of Pathology: 156-160.
60.AL-Khikani, F. H. O. (2020). ”The role of blood group in COVID-19 infection: More information is needed.” Journal of Nature and Science of Medicine 3(3): 225.
61.Ali, S. A., et al. (2020). ”The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat.” Journal of infection and public health.
62.Alraddadi, B. M., et al. (2016). ”Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014.” Emerging infectious diseases 22(1): 49.
63.Amin, P., et al. (2018). ”Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.” Proceedings of the National Academy of Sciences 115(26): E5944-E5953.
64.Anvari, M. S., et al. (2009). ”ABO blood group and coronary artery diseases in Iranian patients awaiting coronary artery bypass graft surgery: a review of 10,641 cases.” Laboratory Medicine 40(9): 528-530.
65.Ashraf, M. A., et al. (2020). ”COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes.” medRxiv.
66.Bener, A. and M. Yousafzai (2014). ”The distribution of the ABO blood groups among the diabetes mellitus patients.” Nigerian journal of clinical practice 17(5): 565-568.
67.Cai, H., et al. (2020). ”Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID19) in Hubei, China.” Med Sci Monit 26: e924171.
68.Cakebread, J. A., et al. (2011). ”Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.” Journal of Allergy and Clinical Immunology 127(5): 1148-1154. e1149.
69.Chan, J. F.-W., et al. (2020). ”Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.” Emerging microbes & infections 9(1): 221-236.
70.Chen, L., et al. (2020). ”Convalescent plasma as a potential therapy for COVID-19.” The Lancet Infectious Diseases 20(4): 398-400.
71.Cooling, L. (2015). ”Blood groups in infection and host susceptibility.” Clinical microbiology reviews 28(3): 801-870.
72.Cui, J., et al. (2019). ”Origin and evolution of pathogenic coronaviruses.” Nature Reviews Microbiology 17(3): 181-192.
73.Dhama, K., et al. (2020). ”Coronavirus disease 2019–COVID-19.”
74.Fagherazzi, G., et al. (2015). ”ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study.” Diabetologia 58(3): 519-522.
75.Garrison, R., et al. (1976). ”ABO blood group and cardiovacular disease the Framingham study.” Atherosclerosis 25(2-3): 311-318.
76.Gérard, C., et al. (2020). ”COVID‐19 & ABO blood group: another viewpoint.” British journal of haematology.
77.Greenberg, S. B. (2016). Update on human rhinovirus and coronavirus infections. Seminars in respiratory and critical care medicine, Thieme Medical Publishers.
78.Hamming, I., et al. (2004). ”Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.” The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 203(2): 631-637.
79.Jassim, W. (2012). ”Association of ABO blood group in Iraqis with hypercholesterolaemia, hypertension and diabetes mellitus.” EMHJ-Eastern Mediterranean Health Journal, 18 (8), 888-891, 2012.
80.Kearney, P. M., et al. (2005). ”Global burden of hypertension: analysis of worldwide data.” The lancet 365 (9455): 217-223.
81.Kumar, S., et al. (2020). Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19), Springer: 23-31.
82.Mailles, A., et al. (2013). ”First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.” Eurosurveillance 18 (24): 20502.
83.Motlagh, A., et al. (2020). ”COVID19 prevention & care; a cancer specific guideline.” Archives of Iranian Medicine 23 (4): 255-264.
84.Muniyappa, R. and S. Gubbi (2020). ”COVID-19 pandemic, coronaviruses, and diabetes mellitus.” American Journal of Physiology-Endocrinology and Metabolism 318 (5): E736-E741.
85.Okeke, C. O., et al. (2018). ”Variations in activated partial thromboplastin time and prothrombin time in individuals of A, B, AB, and O blood groups.” Iraqi Journal of Hematology 7 (2): 85.
86.Rabenau, H., et al. (2005). ”Stability and inactivation of SARS coronavirus.” Medical microbiology and immunology 194(1-2): 1-6.
87.Singhal, T. (2020). ”A review of coronavirus disease-2019 (COVID-19).” The Indian Journal of Pediatrics: 1-6.
88.Wu, J. T., et al. (2020). ”Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.” Nature Medicine 26(4): 506-510.
89.Xia, S., et al. (2020). ”Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.” Cell research 30(4): 343-355.
90.Zhang, W., et al. (2020). ”Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.” Emerging microbes & infections 9 (1): 386-389.
91.Zhao, J., et al. (2020). ”Relationship between the ABO Blood Group and the COVID-19 Susceptibility.” medRxiv.